Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on August 16, 2006
J Am Soc Nephrol 17: 2484-2494, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006050525

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006050525v1
17/9/2484    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burns, W. C.
Right arrow Articles by Kantharidis, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burns, W. C.
Right arrow Articles by Kantharidis, P.

Pathophysiology of Renal Disease and Progression

Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product–Induced Tubular Epithelial-to-Mesenchymal Transition: Implications for Diabetic Renal Disease

Wendy C. Burns*, Stephen M. Twigg{dagger}, Josephine M. Forbes*, Josefa Pete*, Christos Tikellis*, Vicki Thallas-Bonke*, Merlin C. Thomas*, Mark E. Cooper* and Phillip Kantharidis*

* Danielle Alberti Memorial Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, and {dagger} Department of Medicine, University of Sydney, Sydney, New South Wales, Australia

Address correspondence to: Prof. Mark Cooper, Danielle Alberti Memorial Centre for Diabetes Complications, Baker Heart Research Institute, PO Box 6492, St. Kilda Road Central, Melbourne, Victoria, 8008, Australia. Phone: +61-3-8532-1362; Fax: +61-3-8532-1480; E-mail: mark.cooper{at}baker.edu.au

Received for publication May 25, 2006. Accepted for publication July 2, 2006.

Epithelial-to-mesenchymal transition (EMT) of tubular cells contributes to the renal accumulation of matrix protein that is associated with diabetic nephropathy. Both TGF-beta1 and advanced glycation end products (AGE) are able to induce EMT in cell culture. This study examined the role of the prosclerotic growth factor connective tissue growth factor (CTGF) as a downstream mediator of these processes. EMT was assessed by the expression of {alpha}-smooth muscle actin, vimentin, E-cadherin, and matrix proteins and the induction of a myofibroblastic phenotype. CTGF, delivered in an adenovirus or as recombinant human CTGF (250 ng/ml), was shown to induce a partial EMT. This was not blocked by neutralizing anti–TGF-beta1 antibodies, suggesting that this action was TGF-beta1 independent. NRK-52E cells that were exposed to AGE-modified BSA (AGE-BSA; 40 µM) or TGF-beta1 (10 ng/ml) also underwent EMT. This was associated with the induction of CTGF gene and protein expression. Transfection with siRNA to CTGF was able to attenuate EMT-associated phenotypic changes after treatment with AGE or TGF-beta1. These in vitro effects correlate with the in vivo finding of increased CTGF expression in the diabetic kidney, which co-localizes on the tubular epithelium with sites of EMT. In addition, inhibition of AGE accumulation was able to reduce CTGF expression and attenuate renal fibrosis in experimental diabetes. These findings suggest that CTGF represents an important independent mediator of tubular EMT, downstream of the actions of AGE or TGF-beta1. This interaction is likely to play an important role in progressive diabetic nephropathy and strengthens the rationale to consider CTGF as a potential target for the treatment of diabetic nephropathy.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
T. Q. Nguyen, P. Roestenberg, F. A. van Nieuwenhoven, N. Bovenschen, Z. Li, L. Xu, N. Oliver, J. Aten, J. A. Joles, C. Vial, et al.
CTGF Inhibits BMP-7 Signaling in Diabetic Nephropathy
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2098 - 2107.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. C. K. Leung, L. Y. Y. Chan, K. Y. Tam, S. C. W. Tang, M. F. Lam, A. S. Cheng, K. M. Chu, and K. N. Lai
Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis
Nephrol. Dial. Transplant., September 19, 2008; (2008) gfn524v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Vidyasagar, S. Reese, Z. Acun, D. Hullett, and A. Djamali
HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F707 - F716.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. J. Kattla, R. M. Carew, M. Heljic, C. Godson, and D. P. Brazil
Protein kinase B/Akt activity is involved in renal TGF-{beta}1-driven epithelial-mesenchymal transition in vitro and in vivo
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F215 - F225.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. Q. Nguyen, L. Tarnow, A. Jorsal, N. Oliver, P. Roestenberg, Y. Ito, H.-H. Parving, P. Rossing, F. A. van Nieuwenhoven, and R. Goldschmeding
Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy
Diabetes Care, June 1, 2008; 31(6): 1177 - 1182.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Aragno, R. Mastrocola, G. Alloatti, I. Vercellinatto, P. Bardini, S. Geuna, M. G. Catalano, O. Danni, and G. Boccuzzi
Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats
Endocrinology, January 1, 2008; 149(1): 380 - 388.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege
Treatment targets in renal fibrosis
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Kumpers, F. Gueler, S. Rong, M. Mengel, I. Tossidou, I. Peters, H. Haller, and M. Schiffer
Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1355 - F1362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Djamali
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F445 - F455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Sun, K. Devish, W. J. Langer, P. K. Carmines, and P. H. Lane
Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1681 - F1690.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP